A Study of Delavirdine Used Together With Other Anti-HIV Drugs in HIV-Infected Patients

Completed · Not applicable

Conditions studied: HIV Infections

In brief

The purpose of this study is to see if it is safe and effective to give delavirdine (DLV) in combination with two or three other drugs to HIV-infected patients. The drugs to be used in combination with DLV are zidovudine (ZDV), indinavir (IDV), and lamivudine (3TC).

Key facts

Study ID

NCT00002401

Run by

Pharmacia and Upjohn

People needed

160

Last updated by the study team

2005-06-24

Who can join

Age: 14 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Prior Medication:
• Allowed:
• Less than 1 month prior treatment with zidovudine.

You may not qualify if…

• Prior Medication:
• Excluded:
• Prior indinavir.
• Prior lamivudine.
• Prior protease inhibitors.
• Prior non-nucleoside reverse transcriptase inhibitors.
• 1 month or more prior zidovudine.
• HIV-1 positive.
• CD4 coun tis above 50.
• HIV-1 RNA levels greater than 20,000.

Where it is running

• Pharmacia & Upjohn — Peapack, New Jersey, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.